A recent study has shed light on a critical issue in healthcare: the lack of clinical practice guidelines for surgical patients receiving medications for opioid use disorder (MOUD). The research, conducted by Mark Bicket, M.D., Ph.D., and his team, reveals a concerning trend in the use of MOUD among surgical patients, emphasizing the urgent need for standardized protocols. But here's where it gets controversial...
The study, published in the journal Anesthesiology, analyzed data from 2016 to 2022, focusing on surgeries among adults aged 18-64 who had a claim for buprenorphine, methadone, or extended-release naltrexone (MOUD) within 1 to 180 days before their procedure. The findings are eye-opening: MOUD use rates increased from 154 per 100,000 procedures in 2016 to 240 per 100,000 procedures in 2022, primarily driven by the rise in buprenorphine use. This trend is particularly concerning given the potential risks and complexities associated with anesthesia and surgery for patients on these medications.
The study also revealed that the prevalence of MOUD use increased in all age subgroups except for patients aged 18-34, who experienced a slight decrease. When it comes to the types of surgeries, debridement and orthopedic procedures, such as shoulder arthroplasty, lower extremity amputation, and hip or pelvis fracture open repair, had the highest prevalence of MOUD use. And this is the part most people miss...
The implications of these findings are significant. The study highlights the need for clinical practice guidelines to coordinate care and pain management for patients receiving MOUDs, especially in the context of orthopedic surgery. Without such guidelines, there is a risk of harm to patients, as the study suggests. So, what's the solution?
Establishing evidence-based guidelines for clinicians to handle this patient population is crucial. These guidelines should address the unique challenges and considerations of surgical patients on MOUDs, ensuring safe and effective care. By doing so, healthcare providers can better manage the risks and complexities associated with anesthesia and surgery for these patients, ultimately improving patient outcomes and reducing the death toll from opioid overdose.
